Autologous transplantation of hematopoietic stem cells in patients with newly diagnosed multiple myeloma

Multiple myeloma (MM) is a heterogeneous disease defined by clonal proliferation of plasma cells, a hematological tumor that accounts for 1.0-1.8% of all types of cancer. Over the last decades, survival rates for patients with multiple myeloma markedly increased mainly due to the use of autologous stem cell transplantation (Auto-HSCT) and new highly efficacious rescue therapies. For patients